Lourdes Felix
Chief Executive Officer en BIOCORRX INC. .
Fortuna: 123 619 $ al 31/03/2024
Perfil
Lourdes Felix is the founder of BioCorRx Pharmaceuticals, Inc. She currently holds multiple positions as a Director, CFO, Chief Executive & Operating Officer at BioCorRx, Inc. Additionally, she serves as an Independent Director at Siyata Mobile, Inc., Lichen China Ltd., Vocodia Holdings Corp., Avalon GloboCare Corp., and La Rosa Holdings Corp.
Ms. Felix completed her undergraduate degree in 2005 from the University of Phoenix and holds an MBA from D'Amore-Mckim School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOCORRX, INC.
0.93% | 28/03/2024 | 80 395 ( 0.93% ) | 71 954 $ | 31/03/2024 |
BIOCORRX, INC.
25.00% | 25/03/2024 | 40 000 ( 25.00% ) | 35 800 $ | 31/03/2024 |
BIOCORRX, INC.
12.50% | 25/03/2024 | 10 000 ( 12.50% ) | 8 950 $ | 31/03/2024 |
Vocodia Holdings Corp.
0.06% | 14/02/2024 | 5 000 ( 0.06% ) | 3 990 $ | 31/03/2024 |
| 04/04/2024 | 2 500 ( 0.01% ) | 2 925 $ | 31/03/2024 | |
AVALON GLOBOCARE CORP.
-.--% | 01/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Lourdes Felix
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOCORRX INC. | Chief Executive Officer | 09/11/2020 |
| SIYATA MOBILE INC. | Director/Board Member | 29/10/2021 |
| LICHEN CHINA LIMITED | Director/Board Member | - |
| AVALON GLOBOCARE CORP. | Director/Board Member | 09/01/2023 |
| LA ROSA HOLDINGS CORP. | Director/Board Member | 17/04/2024 |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Founder | - |
| Vocodia Holdings Corp. | Director/Board Member | 22/02/2024 |
Formación de Lourdes Felix.
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BIOCORRX INC. | Health Services |
| AVALON GLOBOCARE CORP. | Health Technology |
| SIYATA MOBILE INC. | Electronic Technology |
| LA ROSA HOLDINGS CORP. | Finance |
| Empresas privadas | 3 |
|---|---|
| Lichen China Ltd. | |
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The private company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
| Vocodia Holdings Corp. |
- Bolsa de valores
- Insiders
- Lourdes Felix
